Enlibio，Your biological research partner
！
Xinqidi
Biotech
Co.,Ltd,Wuhan,China 2008-2022
R&D 14th year
Home
Home
Products
Nav
News
Nav
Contact Us
Nav
About Us
Nav
Distributors
Nav
Sitemap
Nav
Human ELISA Kits
Mouse ELISA kits
Rat ELISA kits
Other species ELISA kits
ELISA Kit Assist Reagents
ELISAs
Primary Antibody
Secondary Antibody
Industrial Antibody development
Antibody Development Services
Antibody Related Reagents
Western blot Reagents
Immunohistochemistry Reagents
Antibodies
Recombinant Proteins
Natural Proteins
Peptides
Protein service
Peptide service
Immunogens
Cell Line
Download Manual
Xinqidi News
Biological abstract
Contact Us
Technical Support
Messages
About Us
Job Opportunity
Company structure
Picture show
Biological abstract
Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance
[ Biological abstract ]
2022-07-15
Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
[ Biological abstract ]
2022-07-15
Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodul
[ Biological abstract ]
2022-07-15
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line tr
[ Biological abstract ]
2022-07-15
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
[ Biological abstract ]
2022-07-01
Network-based machine learning approach to predict immunotherapy response in cancer patients
[ Biological abstract ]
2022-07-01
Inactivation of the Hippo tumor suppressor pathway promotes melanoma
[ Biological abstract ]
2022-07-01
Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors
[ Biological abstract ]
2022-07-01
Bioorthogonally activatable cyanine dye with torsion-induced disaggregation for in vivo tumor imagin
[ Biological abstract ]
2022-06-28
Genome-wide mapping of somatic mutation rates uncovers drivers of cancer
[ Biological abstract ]
2022-06-28
Single-cell analyses define a continuum of cell state and composition changes in the malignant trans
[ Biological abstract ]
2022-06-28
EphB4 and ephrinB2 act in opposition in the head and neck tumor microenvironment
[ Biological abstract ]
2022-06-28
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
[ Biological abstract ]
2022-06-02
Persister state-directed transitioning and vulnerability in melanoma
[ Biological abstract ]
2022-06-02
Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemog
[ Biological abstract ]
2022-06-02
The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers
[ Biological abstract ]
2022-06-02
Predicting cancer prognosis and drug response from the tumor microbiome
[ Biological abstract ]
2022-05-31
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhib
[ Biological abstract ]
2022-05-31
Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche
[ Biological abstract ]
2022-05-31
Mutational signatures are markers of drug sensitivity of cancer cells
[ Biological abstract ]
2022-05-31
Prev
1
2
3
...
61
Next
Tel:+86-027-87610298
Tel:
+86-027-87610297
mail:
info@enlibio.com
mail:
sale@enlibio.com
mail:
alex@enlibio.com
mail:
order@enlibio.com
Add:Room A11-329, 1st Floor, No.1, SBI Venture Street, Optics Valley, East Lake
New Technology Development Zone, Wuhan, China.
Certificate NO.:U18Q28010569R0S
